Influence of acute physical exercise on emerging muscular biomarkers

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 9, 2008, Pages 1313-1318

  Lippi, Giuseppe ^a,b   Schena, Federico ^a   Montagnana, Martina ^a   Salvagno, Gian Luca ^a   Guidi, Gian Cesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Markers; Muscle; Running; Sport; Troponin

Indexed keywords

CARBONATE DEHYDRATASE III; CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; GLYCOGEN PHOSPHORYLASE; ISCHEMIA MODIFIED ALBUMIN; MYOGLOBIN; TROPONIN I;

ADULT; ARTICLE; ATHLETE; BIOCHIP; COLORIMETRY; EXERCISE; HEART MUSCLE INJURY; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN FOLDING; RUNNING;

ADULT; BIOLOGICAL MARKERS; EXERCISE; HUMANS; MALE; MIDDLE AGED; MUSCLES; MYOCARDIUM; RUNNING;

EID: 51849153322     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.250     Document Type: Article

References (37)

1. Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-95.
2. Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, et al. Committee on Standardization of Markers of Cardiac Damage of the IFCC. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005;51:810-24.
3. Panteghini M. Acute coronary syndrome: biochemical strategies in the troponin era. Chest 2002;122:1428-35.
4. Panteghini M, Pagani F, Bonetti G. The sensitivity of cardiac markers: an evidence-based approach. Clin Chem Lab Med 1999;37:1097-106.
5. Pope JH, Selker HP. Diagnosis of acute cardiac ischemia. Emerg Med Clin North Am 2003:21:27-59.
6. International Liaison Committee on Resuscitation. Part 5: acute coronary syndromes. Resuscitation 2005;67:249-69.
7. Bayley MD, Schwartz JS, Shofer FS, Weiner M, Sites FD, Traber KB, et al. The financial burden of emergency department congestion and hospital crowding for chest pain patients awaiting admission. Ann Emerg Med 2005;45:110-7.
8. Panteghini M, Apple FS, Christenson RH, Dati F, Mair J, Wu AH, IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. Use of biochemical markers in acute coronary syndromes. Clin Chem Lab Med 1999;37:687-93.
9. Di Serio F, Amodio G, Ruggieri E, De Sario R, Varraso L, Antonelli G, et al. Proteomic approach to the diagnosis of acute coronary syndrome: preliminary results. Clin Chim Acta 2005;357:226-35.
10. Capelli C, Schena F, Zamparo P, Monte AD, Faina M, di Prampero PE. Energetics of best performances in track cycling. Med Sci Sports Exerc 1998;30:614-24.
11. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Standardization of ischemia-modified albumin testing: adjustment for serum albumin. Clin Chem Lab Med 2007;45:261-2.
12. Gidenne S, Ceppa F, Fontan E, Perrier F, Burnat P. Analytical performance of the albumin cobalt binding (ACB) test on the Cobas MIRA Plus analyzer. Clin Chem Lab Med 2004;42:455-61.
13. Maughan RJ, Whiting PH, Davidson RJ. Estimation of plasma volume changes during marathon running. Br J Sports Med 1985;19:138-41.
14. Apple FS, Wu AH. Myocardial infarction redefined: role of cardiac troponin testing. Clin Chem 2001;47:377-9.
15. Brancaccio P, Limongelli FM, Maffulli N. Monitoring of serum enzymes in sport. Br J Sports Med 2006;40:96-7.
16. Brancaccio P, Maffulli N, Limongelli FM. Creatine kinase monitoring in sport medicine. Br Med Bull 2007;81-82:209-30.
17. Smith JE, Garbutt G, Lopes P, Pedoe DT. Effects of prolonged strenuous exercise (marathon running) on biochemical and haematological markers used in the investigation of patients in the emergency department. Br J Sports Med 2004;38:292-4.
18. Munjal DD, McFadden JA, Matix PA, Coffman KD, Cattaneo SM. Changes in serum myoglobin, total creatine kinase, lactate dehydrogenase and creatine kinase MB levels in runners. Clin Biochem 1983;16:195-9.
19. Peetz D, Post F, Schinzel H, Schweigert R, Schollmayer C, Steinbach K, et al. Glycogen phosphorylase BB in acute coronary syndromes. Clin Chem Lab Med 2005;43:1351-8.
20. Rabitzsch G, Mair J, Lechleitner P, Noll F, Hofmann U, Krause EG, et al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin Chem 1995;41:966-78.
21. Kato K, Mokuno K. Distribution of immunoreactive carbonic anhydrase III in various human tissues determined by a sensitive enzyme immunoassay method. Clin Chim Acta 1984;141:169-77.
22. Mokuno K, Riku S, Matsuoka Y, Sobue I, Kato K. Serum carbonic anhydrase III in progressive muscular dystrophy. J Neurol Sci 1985;67:223-8.
23. Mokuno K, Riku S, Matsuoka Y, Kato K. Serum carbonic anhydrase III in myotonic dystrophy. Muscle Nerve 1986;9:257-60.
24. Takala TE, Vuori JJ, Rahkila PJ, Hakala EO, Karpakka JA, Alen MJ, et al. Carbonic anhydrase III and collagen markers in serum following cross-country skiing. Med Sci Sports Exerc 1989;21:593-7.
25. Väänänen HK, Leppilampi M, Vuori J, Takala TE. Liberation of muscle carbonic anhydrase into serum during extensive exercise. J Appl Physiol 1986;61:561-4.
26. Zoll J, Ponsot E, Dufour S, Doutreleau S, Ventura-Clapier R, Vogt M, et al. Exercise training in normobaric hypoxia in endurance runners. III. Muscular adjustments of selected gene transcripts. J Appl Physiol 2006;100:1258-66.
27. Pelsers MM, Glatz JF. Detection of brain injury by fatty acid-binding proteins. Clin Chem Lab Med 2005;43:802-9.
28. Zonderland ML, Bär PR, Reijneveld JC, Spruijt BM, Keizer HA, Glatz JF. Different metabolic adaptation of heart and skeletal muscles to moderate-intensity treadmill training in the rat. Eur J Appl Physiol Occup Physiol 1999;79:391-6.
29. van Breda E, Keizer HA, Vork MM, Surtel DA, de Jong YF, van der Vusse GJ, et al. Modulation of fatty-acid-binding protein content of rat heart and skeletal muscle by endurance training and testosterone treatment. Pflugers Arch 1992;421:274-9.
30. Yuan Y, Kwong AW, Kaptein WA, Fong C, Tse M, Glatz JF, et al. The responses of fatty acid-binding protein and creatine kinase to acute and chronic exercise in junior rowers. Res Q Exerc Sport 2003;74:277-83.
31. Sorichter S, Mair J, Koller A, Pelsers MM, Puschendorf B, Glatz JF. Early assessment of exercise induced skeletal muscle injury using plasma fatty acid binding protein. Br J Sports Med 1998;32:121-4.
32. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. Can J Emerg Med 2006;8:27-31.
33. Lippi G, Montagnana M, Guidi GC. Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia? Int J Cardiol 2006;108:410-1.
34. Apple FS, Quist HE, Otto AP, Mathews WE, Murakami MM. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 2002;48:1097-100.
35. Sbarouni E, Georgiadou P, Theodorakis GN, Kremastinos DT. Ischemia-modified albumin in relation to exercise stress testing. J Am Coll Cardiol 2006;48:2482-4.
36. Thompson PD, Apple FS, Wu A. Marathoner's heart? Circulation 2006;114:2306-8.
37. Smith JE, Garbutt G, Lopes P, Pedoe DT. Effects of prolonged strenuous exercise (marathon running) on biochemical and haematological markers used in the investigation of patients in the emergency department. Br J Sports Med 2004;38:292-4.